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Abstract
Background: The aldo-keto reductase family 1 member C1 (AKR1C1) belongs to a superfamily of NADPH-
dependent reductases that convert a wide range of substrates, including carbohydrates, steroid hormones, and
endogenous prostaglandins. The 20alpha-hydroxysteroid dehydrogenase (20alpha-HSD) is a member of AKR family.
The aims of this study were to determine its expression in the ovary and uterus endometrium during the estrous
cycle and pregnancy.
Methods: Rapid amplification of cDNA ends (RACE) experiments were performed to obtain the 5’ and 3’ ends of
the porcine 20alpha-HSD cDNA. Reverse-transcriptase-PCR (RT-PCR), real-time PCR, northern blot analysis, and
western blot analysis were performed to examine the expression of porcine 20alpha-HSD. Immunohistochemical
analysis was also performed to determine the localization in the ovary.
Results: The porcine 20alpha-HSD cDNA is 957 bp in length and encodes a protein of 319 amino acids. The
cloned cDNA was virtually the same as the porcine AKR1C1 gene (337 amino acids) reported recently, and only
differed in the C-terminal region (the AKR1C1 gene has a longer C-terminal region than our sequence). The
20alpha-HSD gene (from now on referred to as AKR1C1) cloned in this paper encodes a deletion of 4 amino acids,
compared with the C-terminal region of AKR1C1 genes from other animals. Porcine AKR1C1 mRNA was expressed
on day 5, 10, 12, 15 of the cycle and 0-60 of pregnancy in the ovary. The mRNA was also specifically detected in
the uterine endometrium on day 30 of pregnancy. Western blot analysis indicated that the pattern of AKR1C1
protein in the ovary during the estrous cycle and uterus during early pregnancy was similar to that of AKR1C1
mRNA expression. The recombinant protein produced in CHO cells was detected at approximately 37 kDa.
Immunohistochemical analysis also revealed that pig AKR1C1 protein was localized in the large luteal cells in the
early stages of the estrous cycle and before parturition.
Conclusions: Our study demonstrated that AKR1C1 mRNA and protein are coordinately expressed in the luteal cell
of ovary throughout the estrous cycle and in the uterus on day 30 of pregnancy. Thus, the porcine AKR1C1 gene
might control important mechanisms during the estrous cycle.
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The aldo-keto reductase (AKR) superfamily are mono-
meric oxidoreductases that catalyze the NADP(H)-depen-
dent reduction of a wide variety of substrates, including
steroids, prostaglandins, bile acids, carbohydrates, and
xenobiotics [1]. A group of AKRs known as hydroxyster-
oid dehydrogenases (HSDs) play a pivotal role in the mod-
ulation and regulation of steroid hormones [2], such as
androgens, estrogens, and progestins, and are thus consid-
ered important targets for drug design [3]. AKR1C1, a
member of the AKR1C subfamily (that shows both 20a-
and 3a-HSD activities), plays a major role in progesterone
metabolism and maintenance of pregnancy through the
formation of progestin. AKR1C1 also has high 20a-HSD
activity [4]. Animal AKRs are involved in a wide range of
cellular processes that include the biosynthesis of steroid
hormones in classical steroidogenic tissues [1].
The products of AKR activity have been implicated in
prostate disease, breast cancer, obesity, polycystic ovary
disease, and delay in onset of puberty in humans [5,6].
AKR1C genotypes are associated with nipple number as
well as having possible effects on age at puberty and ovula-
tion rate in pigs [7]. In swine, the rate of pubertal develop-
ment and successful pregnancy in gilts affects the efficient
management of breeding females. Human AKR1C1 (20a-
HSD) has been functionally expressed in the fission yeast,
and that this has enabled the resulting yeast strain to effi-
ciently catalyze the reduction of progesterone to 20a-dihy-
droprogesterone. Thus, the process of AKR-dependent
whole-cell biotransformation has been established, to be
used for the production of human AKR metabolites on a
large scale [8].
A tissue distribution study has demonstrated that 20a-
HSD is expressed in the placenta, but not in the adrenal
gland, liver, or spleen during pregnancy. The 20a-HSD
mRNA is expressed in the uterus and fetal skin during
pregnancy and has been suggested to play a role in main-
taining pregnancy in goats [9]. The 20a-HSD enzyme
plays a critical role in the regulation of luteal function
and is also localized in the placenta of rats [10], goats [9],
and humans [4]. Histochemical data have illustrated
strong 20a-HSD activities in several large luteal cells but
not in granulosa cells [11,12]. In ruminant animals, goat
20a-HSD mRNA is mainly localized in the endometrial
epithelium on the caruncle side of the placenta [13]. In
pigs, all AKR1C genes are expressed in adult tissues
(spleen, lung, ovary, adrenal, gland, kidney, and endome-
trium). Pig AKR1C4 is expressed in all tissues, and
AKR1C2 i st h eo n l yo t h e rAKR1C gene expressed in the
brain [7]. The AKR1C1 gene is widely expressed in adult
tissues, but is not expressed in the pancreas, pituitary
gland, small intestine, or brain. However, the regulation
of the temporal expression pattern of AKR1C1 in
reproductive tissues (ovary and uterus) during the estrous
cycle and pregnancy are not completely understood.
To gain further insights into the expression and locali-
zation of AKR1C1 in the porcine ovary and uterine
endometrium during the estrous cycle and pregnancy,
we analyzed the mRNA and protein using RT-PCR,
real-time PCR, northern blot analysis, western blot ana-
lysis, and immunohistochemistry.
Methods
Materials
The cloning vector pCR2.1, expression vectors pcDNA3
and pcDNA4/HisMax, GeneRacer kit, and Super Script™
First-Strand synthesis system were purchased from Invi-
trogen Life Technologies (Carlsbad, CA). The GLASS-
MILK gel extraction kit was purchased from Q-BIO gene
(Cambridge, UK). Restriction enzymes and DNA ligation
k i t sw e r eb o u g h tf r o mT a k a r a( T o k y o ,J a p a n ) .T h eO n e -
S t e pS Y B RR T - P C Rk i tw a sp u r c h a s e df r o mT o y o b o
(Osaka, Japan). Pro-PREP™ protein extraction solution
was purchased from Intron Biotechnology (Seoul, Korea).
The Digoxigenin (DIG) DNA labeling kit and Lumi-Light
western blot kit were bought from Roche (Roche,
Germany). Horse serum, goat serum, the avidin-biotin-
horseradish peroxidase (ABC) detection kit, 3,3’-diamino-
benzidine (DAB), hematoxylin, and methyl green were
purchased from Vector Laboratories (Burlinggame, CA).
Anti-rabbit immunoglobulins and anti-rabbit Alexa 488
secondary antibody were bought from Dako Cytomation.
E-scherichia. coli competent cells (ECOS) were obtained
from Yeastern Biotech Co. Ltd. (Seoul, Korea). CHO-K1
cells were obtained from the Japanese Cancer Research
Resources Bank (Tokyo, Japan). Ham’s F-12, Opti-Mini-
mal Essential Medium (MEM) I, serum-free CHO-S-SFM
II, and Lipofectamine™ 2000 reagents were bought from
Gibco BRL (MD, USA). Fetal bovine serum was from
Hyclone Laboratories (UT, USA). The oligonucleotides
were synthesized by Genotech (Daejon, Korea), and all
other chemicals were obtained from local suppliers.
Tissues
Ovary tissues were obtained by laparotomy of pigs
under general anesthesia on days 0, 2, 5, 10, and 15 of
the estrous cycle. Ovaries were also collected from pigs
on days 0, 30, and 60 of pregnancy, and before parturi-
tion. Uteri were obtained from pigs on days 12 and 15
of the estrous cycle, and at days 12, 15, and 30 of preg-
nancy. Tissues were completely washed 2 times in ice-
cold phosphate-buffered saline (pH 7.2) and dissected
into small fragments. Tissues were snap-frozen in liquid
nitrogen and stored at -80°C. The experiments were
conducted according to the Guidelines for the Care and
Use of Animals, Hankyong National University.
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PCR primers were designed according to the previously
reported homologous part of the 20a-HSD cDNA
sequence [4,9,13]. The specific primers (sense: 5’-GTG
AAG AGA GAA GAC ATA TTC-3’ and antisense: 5’-
CCA CGT TGT ATC TGG TAG CGA AGG-3’)w e r e
synthesized from the nucleotide sequence of the cloned
20a-HSD gene. Total RNA was extracted using the Trizol
reagent. cDNA synthesis was performed using the Super-
Script™ First-Strand Synthesis System according to the
manufacturer’s instructions. PCR was performed with 2.5
units of pfu polymerase in Quick Thermo-II using the fol-
lowing parameters: 30 cycles of denaturation (91°C for
1 min), annealing (37°C for 1 min), and extension (72°C
for 2 min). The PCR products were analyzed by electro-
phoresis in Tris-acetate containing EDTA (TAE). The
PCR fragments (572 bp) were ligated into the pCR2.1
vector and sequence data were analyzed using computer
software (DNASIS).
3’- and 5’-Rapid Amplification of cDNA Ends system
GeneRacer 3’-primer (5’-GCT GTC AAC GAT ACG CTA
CGT AAC G-3’), and GeneRacer 3’-nested primer (5’-
CGC TAC GTA ACG GCA TGA CAG TG-3’)f o r3 ’-
rapid amplification of cDNA ends (RACE) were designed
according to the nucleotide sequence of the resulting PCR
product. The gene specific primer (GSP) GeneRacer 5’-pri-
mer (5’-CGA CTG GAG CAC GAG GAC ACT GA-3’),
and the GeneRacer 5’-nested primer (5’-GGA CAC TGA
CAT GGA CTG AAG GAG TA-3’)f o r5 ’-RACE were
designed according to the nucleotide sequence of the
resulting PCR product. The 3’- and 5’-RACE experiments
were performed using the GeneRacer kit (Invitrogen,
USA) and conducted according to the manufacturer’s
instructions. To confirm the sequence accuracy for the
stop codon in the 3’-terminal region, we conducted the
PCR with specific primers (sense: 5’-GTG AAG AGA
GAA GAC ATA TTC-3’ and antisense: 5’-GAA GTG
TCT GCA CTT CTG AAA GCT-3’).
RT-PCR and real-time PCR of porcine AKR1C1 mRNA
expression
RT-PCR was performed using the AccuPower RT-PCR kit
(RT/PCR PreMix). Total RNA (1.0 μg) extracted from the
pig ovary on days 0, 5, 10, and 15 of the estrous cycle was
mixed with the reverse primer (5’-GCC ATT GCC AAA
AAG CAC AAG-3’), incubated at 70°C for 5 min, and
placed on ice. The forward primer (5’-GGA AAG CGG
ATA GTC AGG GTG ATC-3’) was then added, and the
reaction volume was brought to 20 μL by adding diethyl-
pyrocarbonate-distilled water (DEPC-DW). The cDNA
synthesis reaction was performed using the following para-
meters: 42°C for 60 min and 94°C for 5 min. PCR was car-
ried out according to the following parameters: 94°C for
1 min, followed by 30 cycles (94°C for 1 min, 56°C for
1.5 min, and 72°C for 1 min), followed by a final extension
at 72°C for 8 min. Primers for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) were used for the normalization
of porcine 20a-HSD expression and the primer sequences
of the forward and reverse primers were 5’-ACC ACA
GTC CAT GCC ATC AC-3’ and 5’-TCC ACC ACC CTG
TTG CTG TA-3’, respectively. The expected length of the
PCR fragment was 452 bp. The PCR conditions were 26-
cycles for 10 s at 98°C, 20 s at 55°C, and 20 s at 72°C. Gel
electrophoresis was used to analyze 10 μL of the PCR pro-
ducts. Real-time PCR was carried out using a One-Step
SYBR RT-PCR kit. The real-time PCR amplification mix-
ture consisted of the following reagents: a total of 5 μgo f
RNA, 1× of 2× One-Step SYBR RT-PCR buffer, 5 pmol of
each primer, 2.5 U of Takara Ex Taq HS (Takara, Japan),
50 U of Moloney murine leukemia virus (M-MLV) RTase
(RNase H free), and 20 U of RNase inhibitor. This mixture
was added to PCR tubes, and the reaction volume was
brought to 25 μL by adding RNase-free dH2O. The ther-
mocycler profile was 10 min at 95°C; 30 cycles of 10 s at
95°C, 15 s at 56°C, and 20 s at 72°C; followed by 45 s at
72°C.
Northern blotting analysis
For northern blot analysis, RNA electrophoresis was per-
formed on an agarose gel containing 10’ MOPS and 37%
formaldehyde. The total RNA concentration from pig
ovary and uterus was adjusted to 10 μg/μL. Following
electrophoresis, RNA was transferred overnight to a
membrane with 20’ SSC. The probe was prepared by pur-
ifying the sample after PCR amplification. Probe labeling
was performed with the DIG DNA Labeling Kit. The
membrane was prehybridized for 1 h at 68°C and hybri-
dized at 68°C overnight with DIG-labeled pig AKR1C1
cDNA with gentle rocking. The membrane was subse-
quently washed 2 times with buffer (2’ SSC/0.1% SDS) at
68°C for 5 min with gentle rocking, and 2 times with 0.5’
SSC/0.1% SDS at 68°C for 15 min with gentle rocking.
The anti-DIG antibody (5 μL) was mixed with blocking
reagent, added to the membrane, and incubated at room
temperature (RT) for 1 h. The membrane was washed 2
times with washing buffer at RT for 15 min, and equili-
brated with detection buffer at RT for 5 min. The band
was detected by the addition of CDP-Star reagent.
Western blot analysis
Total protein was extracted using the PRO-PREP™ pro-
tein extraction solution. About 10-20 mg of ovarian and
uterus tissues was used. The samples were then homoge-
nized in 600 μL of PRO-PREP™ solution, and cell lysis
was induced by incubation on ice for 30 min. The tube
was centrifuged at 13,000 rpm at 4°C for 5 min, and the
supernatant was transferred to a fresh 1.5-mL tube.
Seo et al. Reproductive Biology and Endocrinology 2011, 9:139
http://www.rbej.com/content/9/1/139
Page 3 of 10Protein concentration was measured using the Bradford
protein assay [14]. Samples were subjected to SDS-PAGE
and transferred to a polyvinylidene fluoride (PVDF) mem-
brane (0.2 μm) through a semidry electroblotter apparatus.
The membrane was blocked with 1% blocking reagent for
1 h and incubated with a 1:1,500 dilution of bovine-speci-
fic polyclonal 20a-HSD antibody for 1 h. The membrane
was washed to remove unbound antibody and incubated
with a 1:2,000 dilution of a secondary antibody linked to
anti-rabbit IgG-peroxidase (POD) for 30 min. Next, the
membrane was incubated for 5 min with Lumi-Light sub-
strate solution (2 mL), covered with plastic wrap, and
exposed to X-ray film for 1-10 min.
Construction of expression transfer vector and transient
transfection of CHO cell lines
The full-length pig AKR1C1 cDNA was PCR-amplified
with specific primers containing a 5’-end XhoIr e s t r i c -
tion site in the AKR1C1 cDNA sequence, and a 3’-end
XbaI site in the sequence cloned in this study. The PCR
fragments were ligated into the PCR2.1 vector and
sequenced. The fragments digested with XhoIa n dXbaI
restriction enzymes were ligated into eukaryotic expres-
sion vectors (pcDNA3 and pcDNA4/His Max) that had
been digested with XhoIa n dXbaI (designated as
pcDNA3-pAKR1C1 and pcDNA4/His Max-pAKR1C1).
Each vector was completely sequenced to confirm the
presence of the Kozak site and to rule out the possibility
of PCR errors. CHO-KI cell lines were cultured in
growth medium (Ham’s F12 medium containing penicil-
lin [50 U/mL], streptomycin [50 mg/mL], glutamine [2
mM], and 10% fetal calf serum). The cells were incu-
b a t e da t3 7 ° Ci n5 %C O 2. Cultured CHO-K1 cells were
transfected with the expression vectors by using the
liposome transfection method described previously [15].
Briefly, DNA (0.8 μg) was diluted in 50 μLo fO p t i -
MEM I reduced medium without serum and mixed
gently. Lipofectamine 2000 (2 μL) was added gently to a
separate 50-μL aliquot of Opti-MEM I medium. Each
tube was incubated separately for 5 min at RT, after
which the diluted DNA and the diluted Lipofectamine
2000 were combined into a single tube. The 2 samples
were mixed gently and incubated for 20 min. A 100-μL
aliquot of DNA-Lipofectamine 2000 complex was added
to each well, and the samples were incubated for 4-6 h,
and then, 250 μL of 20% FBS was added to each well.
The cells were incubated at 37°C in a CO2 incubator for
24 h. The following day, transfected cells were washed 2
times, placed in 500 μL of serum-free medium, and
incubated at 37°C for 48 h. Next, the culture medium
was removed and the cells were collected into a tube.
Subsequently, the cells were centrifuged at 15,000 rpm
for 10 min, and the cell debris was recovered.
Immunoblot analysis of recombinant pig AKR1C1 protein
Recombinant protein was extracted using PRO-PREP pro-
tein extraction solution. Recombinant AKR1C1 proteins
were subjected to SDS-PAGE and transferred to a PVDF
membrane through a semidry electroblotter apparatus.
The western blot analysis method described above was
followed.
Immunohistochemistry
Immunohistochemical staining was performed using the
Vectastain ABC kit. Ovary samples taken on days 2, 5, 10,
and 15 of the estrous cycle and before parturition were
fixed in 10% neutral buffered formalin at RT for 24 h and
washed with PBS. Next, the fixed samples were dehydrated
in graded ethanol (EtOH) (3 min each in 50%, 2’; 70%, 1’;
95%, 1(; 100%, 1() and dealcoholized with xylene for 2 h
and embedded in paraffin. Paraffin-embedded tissues were
sectioned at 8 μm and mounted onto poly l-lysine-coated
slides and dried at RT. The slides were deparaffinized and
rehydrated (3 min each in xylene, 2(; 100% EtOH, 2(; 95%
EtOH, 1(; 70% EtOH, 1(; 50% EtOH 1() and kept in the
cold tap water. The slides were boiled in 10 mM sodium
citrate for 10 min, left on ice for 20 min, and then washed
in 3% hydrogen peroxide for 10 min and blocked for 1 h
at RT. The slides were first incubated with the primary
antibody for overnight for overnight at 4 C, followed by
the anti-rabbit secondary antibody for 2 h at RT. Finally,
the slides were immunostained using the ABC detection
kit, stained with DAB, and observed under a Nikon Eclipse
TE-2000-E confocal microscope.
Data and statistical analysis
O n e-W a yA N O V AN e w m a n - K e u l sM u l t i p l eC o m p a r i -
son tests were used to compare results between control
and samples, using GraphPad Prism 5 (GraphPad Soft-
ware). Asterisks indicate significant differences from the
control group. (*p < 0.05, **p < 0.01, ***p < 0.001).
Results
Determination of AKR1C1 C-terminal region nucleotide
sequence
The complete cDNA sequence (957 bp) for porcine
AKR1C1 was obtained by assembly of the sequences from
the PCR and RACE fragments. A BLAST search of the
porcine reference genome sequence in the NCBI database
by using the porcine AKR1C1 cDNA did not help identify
the corresponding gene sequence. The porcine AKR1C1
cDNA encodes a protein of 319 amino acids (GenBank:
JN62505). Based on the results of 3’-RACE, we detected a
stop codon in a different site from that of porcine
AKR1C1 reported previously [7]. We sequenced 20 clones
from the 3’-RACE experiment to confirm the sequence
accuracy. This result was different from the 337 amino
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reported, and there was a deletion of 4 amino acids com-
pared with other animal 20a-HSD sequences reported to
date (Figure 1).
Expression of AKR1C1 mRNA by RT-PCR and real-time
PCR
By using the specific primers for porcine AKR1C1 and
amplification by RT-PCR and real-time PCR, porcine
AKR1C1 mRNA was expressed on day 5, 10, 12, 15 of the
cycle and 0-60 of pregnancy in the ovary (Figure 2A, B).
T h eR T - P C Ra n dr e a l - t i m eP C Rr e s u l t sw e r ea l m o s tt h e
same. The AKR1C1 mRNA was detected in all ovarian tis-
sues during the estrous cycle. However, the expression of
AKR1C1 mRNA was particularly strong in the ovary on
day 0 of the estrous cycle. mRNA expression in the ovary
gradually decreased and was very low in the ovary on day
15 of the estrous cycle.
Northern blot analysis
For northern blot analysis, total RNA was extracted from
porcine ovarian tissues on days 5, 10, and 15 of the estrous
cycle, and on days 0, 30, and 60 of pregnancy and before
parturition. Northern blot analysis revealed a 1.2-kb
mRNA in the ovary on day 5 of the estrous cycle and
before parturition (Figure 3A). This pattern was very simi-
lar to the RT-PCR and real-time PCR results. This mRNA
was more intensively expressed in the pre-parturition
ovary than in the ovary at any other period during preg-
nancy (Figure 3B). Next, we analyzed the expression differ-
ence in the ovary on day 12 of the estrous cycle and
pregnancy. An intense pig AKR1C1 mRNA band was
detected with a size of approximately 1.2 kb in the ovary
on day 12 of pregnancy (Figure 4A). Moreover, we also
specifically detected AKR1C1 mRNA in the uterus on day
30 of pregnancy, but it was not detected in the uterus on
days 12 and 15 of the estrous cycle and on days 12 and 15
of pregnancy (Figure 4B).
Western blot analysis of pig ovary tissues
Pig AKR1C1 protein was detected at approximately
37 kDa by western blot analysis, using a specific anti-
bovine 20a-HSD antibody developed in our laboratory.
AKR1C1 protein was detected in all ovaries during the
estrous cycle. The highest expression of the protein was
detected on day 0 of the estrous cycle. Thereafter, its
expression gradually decreased. The level of the protein
was remarkably decreased in the ovary on day 15 of the
estrous cycle (Figure 5A). Comparison of the level of
the AKR1C1 protein with that of the mRNA in ovaries
during the estrous cycle showed a similar pattern. Inter-
estingly, 2 protein bands were detected at approximately
37 and 39 kDa in the ovarian tissues during estrous
cycle (Figure 5A). Next, we analyzed the expression in
the uterus on days 12 and 30 of pregnancy. An intense
protein band was detected with a size of approximately
37 kDa in the uterus on day 30 of pregnancy (Figure
5B). But, it was not detected in the uterus on day 12 of
pregnancy.
Expression of recombinant AKR1C1 in the CHO-K1 cell line
Two expressing vectors (pcDNA3 + pig AKR1C1 and
pcDNA4/HisMax + pig AKR1C1) were transiently trans-
fected into CHO-K1 cells. The cell lysates were col-
lected and subjected to SDS-PAGE. Bovine 20a-HSD-
specific antibody was used to detect the recombinant
protein. The recombinant protein produced by the
pcDNA4/HisMax + pig AKR1C1 expression vector has
a tagging protein of 4 kDa. Thus, the protein produced
in this vector was detected at about 41 kDa. The
recombinant protein of 37 kDa was produced by the
pcDNA3 vector (Figure 6).
Immunohistochemical localization of AKR1C1 protein in
the ovary during the estrous cycle and before parturition
To determine the cell types responsible for AKR1C1
protein expression in the ovary, we performed
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Figure 1 Amino acid alignment of pig AKR1C1 and other animal 20a-HSD proteins. A C-terminal amino acid region of pig AKR1C1
sequence was compared that of bovine, goat, deer, human, rabbit, mouse, and rat 20a-HSD. Dashed lines denote the amino acids identities.
The numbers denote the amino acids before the stop codon. Porcine AKR1C1 denotes the results reported previously [7]. Bold and underlined
AKR1C1 was shown sequence cloned in this paper.
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Page 5 of 10immunohistochemical analysis in the ovary on days 2, 5,
10, and 15 of the estrous cycle and before parturition.
A ss h o w ni nF i g u r e7 ,t h eA K R 1 C 1p r o t e i nw a sl o c a -
lized in large luteal cells. It was intensely expressed in
the luteal cells on days 2 and 5 of the early estrous cycle
(Figure 7B, C). It was also strongly localized in the luteal
cells of ovary at before parturition (Figure 7F). However,
its signal was not detected in the small luteal cells.
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Figure 2 AKR1C1 mRNA expression in the ovary during the estrous cycle. A. AKR1C1 mRNA was detected by RT-PCR. B.R e a l - t i m eP C R
results. Ovarian tissues were obtained by laparotomy under general anesthesia on days 0, 5, 10, and 15 of the estrous cycle. Total RNA was
extracted and then subjected to RT-PCR and real-time PCR. The amplified products of the AKR1C1 and GAPDH genes were separated on agarose
gel and stained with ethidium bromide. Representative results are shown; graphs show the average ± SEM of 3 independent experiments.
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Figure 3 Northern blot analysis of pig AKR1C1 mRNA expression in the ovary during the estrous cycle and pregnancy. A. Ovarian
tissues were obtained by laparotomy under general anesthesia on days 5, 10, and 15 of the estrous cycle. B. Ovaries were collected by the
same method on days 0, 30, and 60 of pregnancy, and before parturition. Blots shown are the results of a representative experiment; graphs
show the average ± SEM of 3 independent experiments. P-part: before parturition.
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In the present study, we determined the expression and
localization of porcine AKR1C1 in the ovary and uterine
endometrium through RT-PCR, real-time PCR, northern
blotting, and immunohistochemistry during the estrous
cycle and pregnancy. Analysis of the nucleotide sequence
 	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Figure 4 Northern blot analysis of pig AKR1C1 mRNA expression in the ovary and uterus during the estrous cycle and pregnancy. A.
Total RNA was isolated from ovaries on day 12 of the estrous cycle and pregnancy. B. Uteri were collected on days 12 and 15 of the estrous
cycle, and on days 12, 15, and 30 of pregnancy. Blots shown are the results of a representative experiment; graphs show the average ± SEM of 3
independent experiments. C: estrous cycle; P: pregnancy.
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Figure 5 Western blot analysis of pig AKR1C1 protein in the ovary during the estrous cycle and pregnancy. A. Pig ovaries on days 0, 5,
10, and 15 of the estrous cycle were obtained by laparotomy under general anesthesia. B. Uteri were collected on days 12, and 30 of
pregnancy. The proteins were transferred onto a PVDF membrane. Proteins on the blot were detected with rabbit anti-bovine 20a-HSD
antibody, followed by staining with secondary antibody linked to anti-rabbit IgG-peroxide. M, marker; p-part, before parturition.
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AKR1C1 cDNA belongs to the AKR family. Both nucleo-
tide and amino acid sequences of the porcine AKR1C1
cloned in this study showed high homology with those of
bovine (86/82%), goat (80/78%), rat (76/66), mouse (76/
68%), and human (81/76%) 20a-HSD. Based on the
results of 3’-RACE, we detected a stop codon in a differ-
ent site from that of porcine AKR1C1 reported previously
[7]. Several conserved sequence patterns were found in
the porcine AKR1C1 cloned in the present study. A cata-
lytic tetrad, such as that consisting of Asp 50, Tyr 55, Lys
84, and His 117, is a common feature of the AKR family
[1]. Other amino acids such as Gly 22, Gly 45, Asp 112,
Pro 119, Gly 164, Asn 167, Pro 186, Gln 190, and Ser 271
are strictly conserved in the primary structure of all
members of the AKR family [2]. Thus, these amino acids
m a yp l a yar o l ei nc o n f e r r i n gt h ea p p r o p r i a t et e r t i a r y
structure necessary for the functional activity.
The present study confirmed that porcine AKR1C1
mRNA is expressed in ovarian tissues during the estrous
cycle. This pattern was similar to the results of RT-PCR
and real-time PCR results. As reported recently, porcine
AKR1C1 gene is widely expressed in adult tissues as deter-
mined in a PCR study by Nonneman et al.[ 7 ] .H o w e v e r ,
these authors did not report on the expression level in the
ovary during the estrous cycle and pregnancy. Although
porcine AKR1C1 mRNA is expressed in several tissues,
our findings suggest that the expression level of AKR1C1
mRNA in the ovary is different in the estrous cycle and in
pregnancy. AKR1C genotypes are associated with nipple
number [16], as well as possibly having effects on age at
puberty and ovulation rate in pigs [7,17].
The expression of pig AKR1C1 mRNA was very differ-
e n tf r o mt h a to fb o v i n ea n dg o a t2 0 a-HSD during the
estrous cycle. The bovine 20a-HSD level was remarkably
higher in the corpus luteum during the late estrous cycle
(unpublished results). On the other hand, goat 20a-HSD
expression was found in the corpus luteum during the
late estrous cycle and expressed in the placenta and inter-
caruncular region of the uterus during mid to late preg-
nancy, but not in the adrenal gland, liver, or spleen
[9,13]. However, human AKR1C1 (20a-HSD) mRNA is
highly expressed in the liver, mammary gland, and brain,
and is expressed at a low levels in the prostate, testis,
adrenal gland, and uterus [4]. Albarracin et al.[ 1 8 ]i n d i -
cated that the pattern of 20a-HSD mRNA expression in
the corpus luteum closely paralleled the ontogeny of
20a-HSD enzyme activity. Pig AKR1C1 mRNA was also
strongly expressed in the ovaries on day 12 of pregnancy
and in the uterine endometrium on day 30 of pregnancy.
Moreover, these results may provide insight into the role
of the AKR1C1 gene at the abovementioned phases of
the estrous cycle and pregnancy. However, the functions
of AKR1C1 in the ovary and uterus during the early
estrous cycle and pregnancy in pigs are not known in
detail. In the present study, we suggest that porcine
AKR1C1 plays a pivotal role on oocyte ovulation and
implantation in ovary and pregnancy maintenance of
fetus in uterus.
On the other hand, 20a-HSD mRNA in goats was
mainly localized in the endometrial epithelium on the
caruncle side of the placenta on day 130 of pregnancy
[13]. In mice, in situ hybridization analysis revealed that
20a-HSD mRNA was localized in the endometrial epithe-
lial cells, maternal placental endothelial cells, and fetal
epidermal cells during pregnancy [19]. These findings
may be related to differences in the distribution of 20a-
HSD between these species. Steroid metabolites of
AKR1C enzymes rise at the onset of puberty [20,21]. FSH
secretion stimulates the development of antral follicles,
and FSH levels are greater in some lines of gilts with
higher ovulation rates [22,23]. Considerable support for
an association between AKR1C genotypes and nipple
number was detected, as well as some indication of an
effect on age at puberty and possible ovulation rate [7].
Age at onset of puberty and ovulation rate at a specific
age are negatively correlated traits in Meishan pigs
because ovulation rate increases from puberty to later
estrous cycles [24].
Pig AKR1C1 protein was most highly expressed in the
ovary on day 0 of the estrous cycle, and was almost consis-
tent with the mRNA expression pattern. This study shows
that AKR1C1 protein and mRNA levels are expressed in a
coordinated fashion in the ovary during the estrous cycle
and pregnancy. However, this is not consistent with results
in other animals, which show the presence of 20a-HSD in
the ovary and placenta [9,11,12,25]. In bovines, its expres-
sion increased according to the phase of the estrous cycle
(unpublished data). However, the pattern in pigs is in
Figure 6 Immunoblot analysis of AKR1C1 recombinant protein
in CHO-K1 cells. The bands corresponding to the protein
produced by pcDNA3 + pAKR1C1 and pcDNA4/HisMax + pAKR1C1
vectors were detected. After gel electrophoresis, the proteins were
transferred to a nitrocellulose membrane. The protein on the blot
was detected with rabbit anti-bovine 20a-HSD, followed by staining
with anti-rabbit IgG-POD. Lane 1, pcDNA3 + pAKR1C1; lane 2,
pcDNA4/HisMax + pAKR1C1.
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The isolated AKR1C1 cDNA was expressed in mammalian
cells, and the protein product was detected by western
blot at 37 kDa, identical to previous reports in other spe-
cies: the baculovirus insect cell system in rat [25] and the
E. coli system in goat, monkey, and rat [9,19,26]. Immuno-
histochemistry demonstrated that AKR1C1 is localized in
large luteal cells. It was intensely expressed in luteal cells
on day 5 of the early estrous cycle and before parturition.
In cattle and deer, 20a-HSD was primarily expressed in
large luteal cells of the corpus luteum during the late
estrous cycle and pregnancy (unpublished data).
However, in pigs, the functions of AKR1C1 on ovulation
have not been reported. This study represents the first
report of specific expression levels and localization in the
ovary and uterus during the estrous cycle and pregnancy
period. Thus, further research is required to elucidate the
function of AKR1C1 in the ovary and uterine endome-
trium during the estrous cycle and pregnancy.
Conclusions
We identified the nucleotide sequence and expression
pattern of the porcine AKR1C1. Our study demonstrated
that AKR1C1 mRNA and protein are coordinately
Figure 7 Immunohistochemical localization of pig AKR1C1 protein in the ovary on days 2, 5, 10, and 15 of the estrous cycle and
before parturition. A. Ovary on day 2 of the estrous cycle (negative control). B. Ovary on day 2 of the estrous cycle. C. Ovary on day 5 of the
estrous cycle. D. Ovary on day 10 of the estrous cycle. E. Ovary on day 15 of the estrous cycle. F. Ovary before parturition. Representative
immunohistochemical analyses are shown for anti-bovine 20a-HSD (1:1,000). Anti-rabbit IgG (1:500) was used as a secondary antibody. For the
negative control, normal rabbit serum (1:100) was used instead of the secondary antibody. Scale bar: 200 um (A, B, C, D, E, and F); 100 um (A’,B ’,
C’,D ’,E ’, and F’), and 50 um (A’’,B ’’,C ’’,D ’’,E ’’, and F’’). Green arrow indicated the granulose layer and black arrow indicate the large luteal cells.
Red arrow indicated the luteal cells.
Seo et al. Reproductive Biology and Endocrinology 2011, 9:139
http://www.rbej.com/content/9/1/139
Page 9 of 10expressed in the ovary throughout the estrous cycle. Por-
cine AKR1C1 mRNA and protein also were highly
expressed in the uterus on day 30 of pregnancy. AKR1C1
was primarily localized in large luteal cells during the
early stages of the estrous cycle and in the ovary before
parturition. Thus, the porcine AKR1C1 gene might con-
trol important mechanisms during the estrous cycle.
Further studies are needed to determine the functional
significance of porcine AKR1C1 during estrous cycle and
pregnancy.
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